• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变模式是影响癌症中功能突变率的一个因素。

Mutation pattern is an influential factor on functional mutation rates in cancer.

作者信息

Du Chuance, Wu Xiaoyuan, Li Jia

机构信息

Department of Urology, Ganzhou Hospital Affiliated to Nanchang University, Ganzhou, Jiangxi province China.

Department of Rehabilitation, Ganzhou Hospital Affiliated to Nanchang University, Nan Chang, Jiangxi province China.

出版信息

Cancer Cell Int. 2016 Feb 9;16:2. doi: 10.1186/s12935-016-0278-5. eCollection 2015.

DOI:10.1186/s12935-016-0278-5
PMID:26865835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4748466/
Abstract

BACKGROUND

Mutation rates are consistently varied in cancer genome and play an important role in tumorigenesis, however, little has been known about their function potential and impact on the distribution of functional mutations. In this study, we investigated genomic features which affect mutation pattern and the function importance of mutation pattern in cancer.

METHODS

Somatic mutations of clear-cell renal cell carcinoma, liver cancer, lung cancer and melanoma and single nucleotide polymorphisms (SNPs) were intersected with 54 distinct genomic features. Somatic mutation and SNP densities were then computed for each feature type. We constructed 2856 1-Mb windows, in which each row (1-Mb window) contains somatic mutation, SNP densities and 54 feature vectors. Correlation analyses were conducted between somatic mutation, SNP densities and each feature vector. We also built two random forest models, namely somatic mutation model (CSM) and SNP model to predict somatic mutation and SNP densities on a 1-Kb scale. The relation of CSM and SNP scores was further analyzed with the distributions of deleterious coding variants predicted by SIFT and Mutation Assessor, non-coding functional variants evaluated with FunSeq 2 and GWAVA and disease-causing variants from HGMD and ClinVar databases.

RESULTS

We observed a wide range of genomic features which affect local mutation rates, such as replication time, transcription levels, histone marks and regulatory elements. Repressive histone marks, replication time and promoter contributed most to the CSM models, while, recombination rate and chromatin organizations were most important for the SNP model. We showed low mutated regions preferentially have higher densities of deleterious coding mutations, higher average scores of non-coding variants, higher fraction of functional regions and higher enrichment of disease-causing variants as compared to high mutated regions.

CONCLUSIONS

Somatic mutation densities vary largely across cancer genome, mutation frequency is a major indication of function and influence on the distribution of functional mutations in cancer.

摘要

背景

癌症基因组中的突变率持续变化,在肿瘤发生中起重要作用,然而,人们对其功能潜力以及对功能性突变分布的影响知之甚少。在本研究中,我们调查了影响突变模式的基因组特征以及癌症中突变模式的功能重要性。

方法

将透明细胞肾细胞癌、肝癌、肺癌和黑色素瘤的体细胞突变及单核苷酸多态性(SNP)与54种不同的基因组特征进行交叉分析。然后计算每种特征类型的体细胞突变和SNP密度。我们构建了2856个1兆碱基窗口,其中每一行(1兆碱基窗口)包含体细胞突变、SNP密度和54个特征向量。对体细胞突变、SNP密度与每个特征向量进行相关性分析。我们还建立了两个随机森林模型,即体细胞突变模型(CSM)和SNP模型,以预测1千碱基规模上的体细胞突变和SNP密度。通过SIFT和Mutation Assessor预测的有害编码变体、用FunSeq 2和GWAVA评估的非编码功能变体以及来自HGMD和ClinVar数据库的致病变体的分布,进一步分析CSM和SNP分数之间的关系。

结果

我们观察到多种影响局部突变率的基因组特征,如复制时间、转录水平、组蛋白标记和调控元件。抑制性组蛋白标记、复制时间和启动子对CSM模型贡献最大,而重组率和染色质组织对SNP模型最为重要。我们发现,与高突变区域相比,低突变区域有害编码突变的密度更高、非编码变体的平均分数更高、功能区域的比例更高且致病变体的富集程度更高。

结论

体细胞突变密度在癌症基因组中差异很大,突变频率是功能的主要指标,且对癌症中功能性突变的分布有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/97aecef317bd/12935_2016_278_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/fc1fe1001e1c/12935_2016_278_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/b15f400d4c8e/12935_2016_278_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/8234e28c02c3/12935_2016_278_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/5f34b3a75f5e/12935_2016_278_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/97aecef317bd/12935_2016_278_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/fc1fe1001e1c/12935_2016_278_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/b15f400d4c8e/12935_2016_278_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/8234e28c02c3/12935_2016_278_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/5f34b3a75f5e/12935_2016_278_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/4748466/97aecef317bd/12935_2016_278_Fig5_HTML.jpg

相似文献

1
Mutation pattern is an influential factor on functional mutation rates in cancer.突变模式是影响癌症中功能突变率的一个因素。
Cancer Cell Int. 2016 Feb 9;16:2. doi: 10.1186/s12935-016-0278-5. eCollection 2015.
2
A comprehensive analysis of cancer-driving mutations and genes in kidney cancer.肾癌中癌症驱动突变和基因的综合分析。
Oncol Lett. 2017 Apr;13(4):2151-2160. doi: 10.3892/ol.2017.5689. Epub 2017 Feb 7.
3
Functional annotation of noncoding variants and prioritization of cancer-associated lncRNAs in lung cancer.肺癌中非编码变异的功能注释及癌症相关长链非编码RNA的优先级排序
Oncol Lett. 2016 Jul;12(1):222-230. doi: 10.3892/ol.2016.4604. Epub 2016 May 18.
4
Prioritization of non-coding disease-causing variants and long non-coding RNAs in liver cancer.肝癌中非编码致病变异体和长链非编码RNA的优先级排序
Oncol Lett. 2016 Nov;12(5):3987-3994. doi: 10.3892/ol.2016.5135. Epub 2016 Sep 14.
5
Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.启动子区域的系统筛选确定了皮肤黑色素瘤基因组中的功能性顺式调控突变。
Mol Cancer Res. 2015 Aug;13(8):1218-26. doi: 10.1158/1541-7786.MCR-15-0146. Epub 2015 Jun 16.
6
Disease-associated variants in different categories of disease located in distinct regulatory elements.位于不同调控元件中的不同疾病类别中的疾病相关变体。
BMC Genomics. 2015;16 Suppl 8(Suppl 8):S3. doi: 10.1186/1471-2164-16-S8-S3. Epub 2015 Jun 18.
7
Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomes.黑色素瘤基因组功能非编码区去分化的突变特征。
PLoS Genet. 2012;8(8):e1002871. doi: 10.1371/journal.pgen.1002871. Epub 2012 Aug 9.
8
Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.基于基因排列模型的不同功能预测评分比较,用于鉴定癌症驱动基因。
BMC Med Genomics. 2019 Jan 31;12(Suppl 1):22. doi: 10.1186/s12920-018-0452-9.
9
Chromatin structure is distinct between coding and non-coding single nucleotide polymorphisms.染色质结构在编码和非编码单核苷酸多态性之间是不同的。
BMC Mol Biol. 2014 Oct 5;15:22. doi: 10.1186/1471-2199-15-22.
10
On the identification of potential regulatory variants within genome wide association candidate SNP sets.在全基因组关联候选 SNP 集中鉴定潜在的调控变异。
BMC Med Genomics. 2014 Jun 11;7:34. doi: 10.1186/1755-8794-7-34.

引用本文的文献

1
Retraction Note to: Mutation pattern is an influential factor on functional mutation rates in cancer.撤稿说明:突变模式是影响癌症功能突变率的一个因素。
Cancer Cell Int. 2017 Jul 5;17:67. doi: 10.1186/s12935-017-0436-4. eCollection 2017.

本文引用的文献

1
Hypermutation in human cancer genomes: footprints and mechanisms.人类癌症基因组中的高突变:印记与机制
Nat Rev Cancer. 2014 Dec;14(12):786-800. doi: 10.1038/nrc3816.
2
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer.FunSeq2:一种对癌症中非编码调控变异进行优先级排序的框架。
Genome Biol. 2014;15(10):480. doi: 10.1186/s13059-014-0480-5.
3
Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites.m6A 甲基化酶的扰动揭示了内部位点和 5' 位点上两种不同类型的 mRNA 甲基化。
Cell Rep. 2014 Jul 10;8(1):284-96. doi: 10.1016/j.celrep.2014.05.048. Epub 2014 Jun 26.
4
Functional annotation of noncoding sequence variants.非编码序列变异的功能注释。
Nat Methods. 2014 Mar;11(3):294-6. doi: 10.1038/nmeth.2832. Epub 2014 Feb 2.
5
Discovery and saturation analysis of cancer genes across 21 tumour types.在 21 种肿瘤类型中发现和饱和分析癌症基因。
Nature. 2014 Jan 23;505(7484):495-501. doi: 10.1038/nature12912. Epub 2014 Jan 5.
6
Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair.癌症基因组调控DNA中局部突变密度降低与DNA修复有关。
Nat Biotechnol. 2014 Jan;32(1):71-5. doi: 10.1038/nbt.2778. Epub 2013 Dec 15.
7
The UCSC Genome Browser database: 2014 update.UCSC 基因组浏览器数据库:2014 年更新。
Nucleic Acids Res. 2014 Jan;42(Database issue):D764-70. doi: 10.1093/nar/gkt1168. Epub 2013 Nov 21.
8
ClinVar: public archive of relationships among sequence variation and human phenotype.ClinVar:序列变异与人类表型之间关系的公共档案。
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5. doi: 10.1093/nar/gkt1113. Epub 2013 Nov 14.
9
Integrative annotation of variants from 1092 humans: application to cancer genomics.综合注释来自 1092 个人类的变异:在癌症基因组学中的应用。
Science. 2013 Oct 4;342(6154):1235587. doi: 10.1126/science.1235587.
10
The Cancer Genome Atlas Pan-Cancer analysis project.癌症基因组图谱泛癌分析项目。
Nat Genet. 2013 Oct;45(10):1113-20. doi: 10.1038/ng.2764.